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Objectives This study evaluated the usefulness of fluorodesoxyglucose marked by fluorine-18 (18F-FDG) positron emission
tomography (PET) and computed tomography (CT) in patients with suspected cardiovascular implantable elec-
tronic device (CIED) infection.
Background CIED infection is sometimes challenging to diagnose. Because extraction is associated with significant morbidi-
ty/mortality, new imaging modalities to confirm the infection and its dissemination would be of clinical value.
Methods Three groups were compared. In Group A, 42 patients with suspected CIED infection underwent 18F-FDG PET/CT.
Positive PET/CT was defined as abnormal uptake along cardiac devices. Group B included 12 patients without
infection who underwent PET/CT 4 to 8 weeks post-implant. Group C included 12 patients implanted for 6
months without infection who underwent PET/CT for another indication. Semi-quantitative ratio (SQR) was ob-
tained from the ratio between maximal uptake and lung parenchyma uptake.
Results In Group A, 32 of 42 patients with suspected CIED infection had positive PET/CT. Twenty-four patients with posi-
tive PET/CT underwent extraction with excellent correlation. In 7 patients with positive PET/CT, 6 were treated
as superficial infection with clinical resolution. One patient with positive PET/CT but negative leukocyte scan was
considered false positive due to Dacron pouch. Ten patients with negative-PET/CT were treated with antibiotics
and none has relapsed at 12.9  1.9 months. In Group B, patients had mild uptake seen at the level of the con-
nector. There was no abnormal uptake in Group C patients. Median SQR was significantly higher in Group A
(A  2.02 vs. B  1.08 vs. C  0.57; p  0.001).
Conclusions PET/CT is useful in differentiating between CIED infection and recent post-implant changes. It may guide appro-
priate therapy. (J Am Coll Cardiol 2012;59:1616–25) © 2012 by the American College of Cardiology
Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.11.059Cardiovascular implantable electronic device (CIED) infec-
tion is one of the most feared complications of device
implantation. The incidence of CIED infections is 1.9 cases
by 1,000 implants/year (1,2). The total number of CIED
infections is increasing, mainly with new clinical indications
and the growing number of implants worldwide (3). Defin-
itive CIED infection diagnosis is often challenging. In
addition, CIED infection treatment can be invasive, requir-
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†Department of Medical Imaging, Division of Nuclear Medicine, Institut universi-
taire de cardiologie et pneumologie de Québec, Québec City, Quebec, Canada. All
authors have reported that they have no relationships relevant to the contents to this
paper to disclose.Manuscript received July 7, 2011; revised manuscript received November 9, 2011,
accepted November 22, 2011.ing complete extraction of the generator and all leads. Lead
extraction is associated with significant morbidity (major
complications  1.5% to 2%) and mortality (0.8%) (4,5).
New imaging modalities to confirm the infectious process
and its dissemination would be of clinical value.
See page 1626
Combined fluorodesoxyglucose marked by fluorine-18
(18F-FDG) positron emission tomography (PET) and com-
puted tomography (CT) is a well-established imaging mo-
dality that allows 3-D measurement of metabolic activity
within an organ obtained from the emission of positrons
following disintegration of an injected radioactive product.
The value of 18F-FDG PET/CT is already recognized in
oncology for cancer diagnosis and staging, and in cardiology
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May 1, 2012:1616–25 PET/CT and Device Infectionto assess myocardial viability. 18F-FDG PET/CT is also
sed for infection detection associated with vascular or
rthopedic prostheses (6–9). There are few case reports
10–13) and only 2 small pilot studies (14,15) in the
iterature where 18F-FDG PET/CT has been used for
IED infection diagnosis. 18F-FDG PET/CT appears as
an interesting adjunct for CIED infection diagnosis because it
allows the use of 18F-FDG as a marker. This is a glucose
nalogue, which is incorporated and retained within the cells
ith higher metabolic activity. It might help the clinician to
onfirm the diagnosis of CIED infection, determine the
ystemic extension of the infectious process, and justify an
nvasive procedure.
The goal of this study was first to evaluate the usefulness
f 18F-FDG PET/CT for the detection of CIED infec-
ions. Secondly, because there is sometimes a real clinical
hallenge to diagnose a CIED infection or superficial skin
nfection or inflammation in recent post-implant patients,
e tested a group of patients with recent implants and no
linical suspicion of infection to assess their “baseline”
18F-FDG uptake level.
Methods
The protocol was approved by the Ethics Committee from
the Institut universitaire de cardiologie et pneumologie de
Quebec.
Three groups of consecutive patients were prospectively
compared. The first group (Group A  suspected CIED
infection) included patients with clinically suspected CIED
infections (n  42). CIED infection was defined by the
presence of 1 of the following (5,16): 1) pocket infection 
local signs of inflammation at the generator pocket, includ-
ing erythema, warmth, fluctuance, wound dehiscence, ten-
derness, or purulent drainage (n  26); 2) device erosion 
cutaneous erosion with percutaneous exposure of the gen-
erator and/or leads (n  6); 3) lead endocarditis  mass
adherent to a lead in a patient with positive blood cultures
or other suggestive features for infection or lead tip cultures
(n  7); and 4) persistent or recurrent bacteremia in the
absence of another identifiable source (n  3).
Treatment decisions were on the basis of the degree of
certainty of the CIED infection diagnosis, results of con-
ventional tests, and clinical guidelines (5). Results of the
18F-FDG PET/CT were transmitted to the treating phy-
sicians, but the exam was only complementary and never
used alone for the final decision on the management of these
patients. Extraction was performed when deep CIED in-
fection (i.e., infection involving the generator and/or the
leads) was suspected. The second group (Group B 
controls: acute phase) included patients with recent device
implantation but without signs of infection in order to know
the background residual inflammation at 4 to 8 weeks
post-implant (n  12), the period where the diagnosis
can be more challenging. These patients were recruited at
the time of their first follow-up visit approximately 1month post-implant. Finally, the
third group (Group C  con-
trols: chronic phase) included
patients with remote device im-
plantation (6 months) with-
ut signs of infection who un-
erwent 18F-FDG PET/CT
for another indication (n  12).
Clinical data were collected
rom all patients, including blood
ork (white blood cell count,
eutrophils count, C-reactive
rotein level, and blood cultures
f available). A clinical correla-
ion was performed in patients
ho had a transesophageal echo-
ardiogram (TEE) and/or ex-
raction in addition to 18F-FDG
ET/CT.
18F-FDG PET/CT. All patients underwent 18F-FDG
PET/CT (GE Discovery PET/CT, GE Healthcare, Pisca-
taway, New Jersey) after an 8-h fasting period. PET imaging
was performed 65 17 min after injection of 8.1 1.8 mCi of
DG (equivalent to 293.1  74.4 MBq). Simultaneously, a
ow-dose CT without intravenous contrast but with gastric
pacification was obtained for attenuation correction and
natomic localization. The capillary glucose was measured
t the time of the injection. Limited imaging to the torso
nd superior abdomen was performed in Group B to limit
adiation exposure.
Each case was reviewed by 2 experienced nuclear physi-
ians. Discordant analyses were resolved by consensus. The
nalysis was performed using MIMvista software (MIM
oftware Inc., Cleveland, Ohio). Both attenuation-
orrected as well as non–attenuation-corrected images were
eviewed in order to recognize artifacts related to the
orrection of attenuation in proximity of an object of high
ensity (e.g., metal of generator), but only the non–
ttenuation-corrected images were used for final interpreta-
ion. A positive 18F-FDG PET/CT was defined as an
abnormal 18F-FDG uptake near the generator pocket
and/or along the CIED (i.e., generator or leads). Sites of
abnormal 18F-FDG uptakes were noted as well as the site of
maximal 18F-FDG uptakes. Sites of abnormal 18F-FDG
ptakes were separated by areas: skin (superficial), subcuta-
eous tissue, surrounding of generator, overlying leads, and
ntravascular/intracardiac. A qualitative visual score was
oted: none (score  0), mild hypermetabolism (equal or
ess to lung parenchyma; score  1), moderate hypermetab-
lism (more intense than lung parenchyma; score  2), and
severe hypermetabolism (very intense uptake; score  3).
There was interobserver agreement for the qualitative visual
score as well as for the final PET/CT conclusion on whether
or not CIED infection was present. A semi-quantitative
ratio was also collected from non–attenuation-corrected
Abbreviations
and Acronyms
18F-FDG 
fluorodesoxyglucose marked
by fluorine-18
CIED  cardiovascular
implantable electronic
device
CT  computed
tomography
LVEF  left ventricular
ejection fraction
PET  positron emission
tomography
ROC  receiver-operating
characteristic
TEE  transesophageal
echocardiogramimages. A ratio was created between the maximum count
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PET/CT and Device Infection May 1, 2012:1616–25rate of the device over a mean count rate between normal
right and left lung parenchyma. Areas of abnormal lung
parenchyma were avoided. Other zones of captation were
avoided (skin, shoulder, thyroid gland). Values for the
semi-quantitative ratio were measured on at least 2 separate
occasions with excellent reproducibility.
Statistical analysis. Data were expressed using the mean
D or the median (interquartile range) for continuous
ariables or as percentage for categorical data. The analyses
f categorical variables were performed using a generalized
inear model with a binary distribution function for the
Figure 1 CIED Infection in a Patient With a Deep Pocket Infec
(Upper panels) Attenuation-corrected (AC) and non–attenuation-corrected (NAC) image
phy (PET) in different planes shows abnormal uptake seen posterior to the generator
infection. (Lower panel) The same abnormality on a fused 18F-FDG PET/computed tomependant variable. For continuous data, a 1-way analysis of
ariance was fitted to compare groups with heterogeneous
ariances and whether the model could be reduced to a
-way analysis with the same variance across groups was
ested. For the time since last intervention and semi-
uantitative ratio, values were log transformed to stabilize
ariances. Reported p values are on the basis of these
ransformations. A posteriori comparisons were performed
sing Tukey’s comparison technique. The univariate nor-
ality assumptions were verified with the Shapiro-Wilk
est. Sensibility and specificity values of 18F-FDG PET/
nd Positive 18F-FDG PET/CT (Group A)
e fluorodesoxyglucose marked by fluorine-18 (18F-FDG) positron emission tomogra-
arrow) and compatible with cardiovascular implantable electronic device (CIED)
hy (CT) (yellow arrow). A  anterior, L  left; P  posterior; R  right.tion a
s of th
(black
ograp
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May 1, 2012:1616–25 PET/CT and Device InfectionCT, on the basis of the qualitative visual score, were assessed
in comparison with the actual gold standard, which is the
clinical definition of CIED infection mentioned previously.
A receiver operating characteristic (ROC) curve was calcu-
lated from the semi-quantitative ratio. A Pearson correla-
tion test was performed between 18F-FDG PET/CT results
and clinical findings at the time of the extraction. The
results were considered significant with p values 0.05. All
Figure 2 Cardiovascular Implantable Electronic Device Infectio
With an Infected Epicardial Lead and Positive 18F-FDG
(Upper panels) AC and NAC images of the 18F-FDG PET in different planes shows
panel) Two images of the same CT transverse section demonstrating abnormal up
plain CT for lead localization (upper component) (yellow arrow  epicardial lead).analyses were conducted using the statistical package SAS
version 9.2 (SAS Institute Inc., Cary, North Carolina).
Results
Patient characteristics. Group A included 42 patients
with suspected CIED infection, on the basis of history,
physical examination, and initial blood tests. This group
Patient
/CT (Group A)
al uptake seen along the course of the epicardial lead (black arrow). (Lower
n the lead with 18F-FDG PET fusion (lower component) and the corresponding
viations as in Figure 1.n in a
PET
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PET/CT and Device Infection May 1, 2012:1616–25comprised 28 men and 14 women with a mean age of 62 
17 years, and a mean left ventricular ejection fraction
(LVEF) of 44  17% (Table 1). All patients underwent
18F-FDG PET/CT for risk stratification, and several pa-
tients also had a TEE (n  22). The main presenting
symptom or sign was local wound infection (n  16),
pre-erosion/erosion (n  13), bacteremia (n  10), fever of
unknown origin (n  1), local persistent swelling (n  1),
and chronic wound discomfort (n  1). Eight patients
without local signs of device infection met the Duke criteria
for infective endocarditis. Twenty-four patients underwent
extraction and 18 patients were treated with antibiotics only.
After complete evaluation, 35 patients had confirmed
CIED infections. In the remaining 7 patients, 5 patients
were treated successfully for an infection unrelated to
their cardiac device, 1 patient with fever of unknown
Figure 3 Recent Post-Implantation Changes on 18F-FDG PET/C
(Upper panels) AC and NAC images of the 18F-FDG PET in different planes shows
right pre-pectoral area (black arrow). (Lower panel) The same result on a fused 1origin was finally diagnosed with reactive arthritis, and 1
patient previously treated for superficial infection but
now with chronic local discomfort had no evidence of
recurrent infection after extensive work-up.
In Group B (controls: acute phase), 12 patients without
signs of infection were enrolled between 4 and 8 weeks
post-implant to undergo 18F-FDG PET/CT in order to
btain background residual inflammation early post-
rocedure. It included 11 men and 1 woman with a mean
ge of 65  8 years and a mean LVEF of 39  13%. The
18F-FDG PET/CT was performed at a median of 1.3
months after the patients’ last cardiac device operation.
Group C (controls: chronic phase) comprised 12 patients
with implanted devices for at least 6 months without any
sign of CIED infection who underwent 18F-FDG PET/CT
or another indication (work-up of lung nodule  8, cancer
a Patient 6 Weeks Post–Device Implantation (Group B)
sidual uptake at the level of the connector on the
PET/CT (yellow arrow). Abbreviations as in Figure 1.T in
mild re
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17
w
2
p
s
o
T
(
p
1621JACC Vol. 59, No. 18, 2012 Sarrazin et al.
May 1, 2012:1616–25 PET/CT and Device Infectionstaging  2, chronic cough  1, pre-transplantation eval-
uation  1). It included 9 men and 3 women with a mean
age of 70  10 years and a mean LVEF of 50  8%.
Blood tests. White blood cells count was 8.5 2.5 109/l
in Group A, 6.6  1.5  109/l in Group B, and 8.9  2.4 
09/l in Group C (p 0.050). Neutrophils count was 6.4
2.6 109/l in Group A, 4.1 1.3 109/l in Group B, and
.2  2.7  109/l in Group C (p  0.016). There was no
significant difference between the median C-reactive pro-
tein levels in Group A and Group B (8.9 mg/l, range 1.3 to
261.3 mg/l vs. 3.8 mg/l, range 0.3 to 8.6; p  0.194).
Figure 4 18F-FDG PET/CT in a Patient With Remote Cardiac De
(Upper panels) AC and NAC images of the 18F-FDG PET in different planes shows
the cardiac device system. The black arrow shows the site of the generator. (Low
(yellow arrow). Abbreviations as in Figure 1.Cultures. In Group A, a total of 24 patients (57%) had
positive cultures. Sites with positive cultures included blood
(n  10), pre-operative wound (n  11), and surgical
ound or lead (n  6). A single organism was identified in
0 patients and multiple organisms were identified in 4
atients. Staphylococcus aureus (n  10), other Staphylococcus
pecies (n  8), Streptococcus species (n  4), and other
rganisms (n  5) were found.
ransesophageal echocardiogram. Twenty-two patients
52%) had a TEE. Vegetations were suspected in 12
atients. The average vegetation size was 7.5  3.5 mm.
Implantation and Lung Nodule Investigation (Group C)
G uptakes of an active right lung nodule but complete absence of uptake along
el) No 18F-FDG uptakes on a fused 18F-FDG PET/CT at the level of the generatorvice
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PET/CT and Device Infection May 1, 2012:1616–25The vegetations were seen on the leads in 7 patients, on the
valves in 2 patients, and on both in 3 patients. However,
increased 18F-FDG uptake in the same anatomical site was
seen in only 6 patients.
18F-FDG PET/CT. Higher doses of 18F-FDG were used
n Group C compared with Group A (370.6  27.5 MBq
s. 288.8  69.6 MBq) (Table 2). The calculated mean
adiation dose for an 18F-FDG PET/CT in the context of
CIED infection was 7.0 mSv, which is less than a coronary
angioplasty. In Group A, 32 of 42 patients (76%) with
suspected CIED infection had a positive 18F-FDG PET/
T. Abnormal uptake was visualized around the generators
n  18), over the leads (n  18), in the superficial skin
Patient CharacteristicsTable 1 Patient Characteristics
Group A
Suspected CIED
Infection
(n  42)
Age, yrs 62 17
Male/female, n 28/14
LVEF, % 44 17
CAD 14 (33)
Diabetes mellitus 11 (26)
Warfarin 18 (43)
Corticosteroids use 3 (7)
Type of device
Pacemaker 25 (60)
Defibrillator 17 (40)
Biventricular device 7 (17)
Number of leads 2.2 0.8
Time since last intervention, months 11.2 (0.3–101.5
Confirmed infection 35 (83)
Values are mean  SD, n (%), or median (minimum to maximum), un
p  0.001; comparison between Group A and Group C, p  0.001; co
CAD  coronary artery disease; CIED  cardiovascular implantable
18F-FDG PET/CT ResultsTable 2 18F-FDG PET/CT Results
Group A
Suspected CIED
Infection
(n  42)
Dose
MBq 288.8 69.6
mCi 7.7 1.8
Maximal SUV 4.4 1.6
Qualitative visual score
Median 2.0
Lower quartile 1.3
Upper quartile 2.5
Semi-quantitative ratio
Median 2.02
Lower quartile 1.30
Upper quartile 2.98
Values are mean SD. *Comparison between Group A and Group B, p
between Group B and Group C, p  0.001. †Comparison between G
C,p  0.001; comparison between Group B and Group C, p  0.010.
18F-FDG PET/CT fluorodesoxyglucose marked by fluorine-18 positron em
implantable electronic device; SUV  standardized uptake value.issue (n  13), in the subcutaneous tissue (n  13), and
ithin the heart (n  2). Figure 1 shows an example of
onfirmed CIED infection with a positive 18F-FDG
PET/CT in a patient with deep pocket infection and
18F-FDG uptake seen posterior to the generator. Figure 2
shows another example of CIED infection in a patient with
pocket infection as well as an infected epicardial lead. Six
patients had 18F-FDG uptake limited to superficial tissues
ithout direct contact with the generator or leads, and were
reated as superficial skin infection with sustained clinical
mprovement at 9.1  6.6 months. One patient with more
xtensive positive 18F-FDG PET/CT was treated with
hronic antibiotic suppressive therapy because of significant
Group B
Controls
Acute Phase
(n  12)
Group C
Controls
Chronic Phase
(n  12) p Value
65 8 70 10 0.189
11/1 9/3 0.315
39 13 50 8 0.053
6 (50) 6 (50) 0.478
1 (8) 2 (17) 0.388
6 (50) 7 (58) 0.730
0 0 1.000
6 (50) 10 (83) 0.259
6 (50) 2 (17)
3 (25) 0 0.781
2.0 0.7 1.8 0.5 0.123
1.3 (1.0–2.1) 24.5 (8.0–130.2) 0.001*
0 0 0.001
herwise specified. *Comparison between Group A and Group B,
on between Group B and Group C, p  0.010.
nic device; LVEF  left ventricular ejection fraction.
roup B
ontrols
te Phase
 12)
Group C
Controls
Chronic Phase
(n  12) p Value
.0 70.8 370.6 27.5 0.001
.3 1.6 9.9 0.9 0.002
.2 1.4 0 0.001
0.8 0 0.001*
0.5
1.0
1.08 0.57 0.001†
0.84 0.40
1.31 0.62
1; comparison between Group A and Group C, p 0.001; comparison
and Group B, p  0.005; comparison between Group A and Group)
less otG
C
Acu
(n
248
7
1
 0.00
roup Aission tomography and computed tomography; CIED cardiovascular
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May 1, 2012:1616–25 PET/CT and Device Infectioncomorbidities (elderly woman with severe cachexia). One
patient with positive 18F-FDG PET/CT but negative
leukocyte scan was considered a false positive due to a
Dacron pouch surrounding the device. Ten patients with
negative 18F-FDG PET/CT were treated with antibiotics
only and none had relapsed at 12.9  1.9 months (initial
diagnoses  local superficial infection in 4, bacteremia in 5,
and fever of unknown origin in 1).
In Group B, patients had no or mild uptake only seen at
the level of the connector. Figure 3 shows an example of a
patient with presence of mild residual inflammation 4 to 8
weeks post–device implantation at the level of the connec-
tor. There was no abnormal uptake in any of Group C
patients. Figure 4 shows an example of a patient undergoing
lung nodule investigation with remote cardiac device im-
plantation and complete absence of 18F-FDG uptake along
he cardiac device system.
ualitative visual score and semi-quantitative ratio of
18F-FDG PET/CT. The median qualitative visual score was
ignificantly higher in Group A (A  2.0 [lower quartile 
.3, upper quartile 2.5] vs. B 0.8 [lower quartile 0.5,
upper quartile  1.0] vs. C  0; p  0.001). The median
semiquantitative ratio was also significantly higher in Group
A (A  2.02 [lower quartile  1.30, upper quartile  2.98] vs.
B  1.08 [lower quartile  0.84, upper quartile  1.31] vs.
C  0.57 [lower quartile  0.40, upper quartile  0.62];
 0.001).
ensitivity and specificity of 18F-FDG PET/CT. On the
basis of the qualitative visual score, the sensitivity of
18F-FDG PET/CT for diagnosis of CIED infection in
Group A was 0.886 (95% confidence interval: 0.723 to
0.963) with a specificity of 0.857 (95% confidence interval:
0.420 to 0.992). On post-hoc analysis using the semi-
quantitative ratio, an ROC curve revealed an area under the
curve at 0.887 (p  0.001) for all 3 groups (Fig. 5). Using
a ratio greater than 1.87, a specificity of 100% was achieved,
meaning that all patients had confirmed CIED infections.
After exclusion of acute controls (Group B), the ROC curve
showed a higher area under the curve at 0.961 (p  0.001)
with no chronic controls (Group C) having a semi-
quantitative ratio above 1.00.
Extraction. Twenty-four patients with positive 18F-FDG
PET/CT underwent complete extraction with excellent
correlation between sites of 18F-FDG uptakes and the
ocalization of infection at the time of the extraction (0.798;
 0.001). In 20 patients with confirmed deep pocket
nfection during the extraction, 19 patients had significant
18F-FDG uptakes in the same anatomical location; 1
patient had pocket tissue induration during the extraction
but no 18F-FDG uptakes at that site, although the same
atient also had vegetation seen on TEE and corresponding
18F-FDG uptake on the lead. Finally, 4 patients underwent
extraction for bacteremia and lead vegetations seen on TEE
without signs of pocket infection; in these patients, the
18F-FDG PET/CT revealed 18F-FDG uptakes on the lead
ut no 18F-FDG uptakes at the level of the pocket.iscussion
ain findings. 18F-FDG PET/CT is helpful to differen-
iate between an active cardiac device infection and residual
ormal post-operative inflammation still sometimes present
to 8 weeks after the operation. The ratio between maximal
evice count and normal lung parenchyma allows adequate
ifferentiation between post-operative inflammation and
ctive infection. In addition, patients with absence of
18F-FDG uptakes despite an initial suspicion of CIED
infection had a good outcome with initial antibiotic therapy
alone, suggesting that 18F-FDG PET/CT could help in risk
tratification and decision management of these patients.
18F-FDG PET/CT results. 18F-FDG PET/CT was pos-
tive in 31 patients with confirmed CIED infection. There
as only 1 false positive case related to the presence of a
acron pouch surrounding the generator; Keidar et al. (6)
reviously described a similar mild 18F-FDG uptake as a
post-operative foreign-body inflammatory reaction. The
diagnosis of CIED infection was obvious in some patients
with device erosion or local signs of infection, but not in
several other patients. In addition, the presence of a positive
18F-FDG PET/CT combined to a more extensive 18F-
FDG anatomical distribution had a significant impact on
the final management of these patients. Indeed, most
patients with evidence of deep infection (24 of 27 patients)
underwent extraction as opposed to patients with a limited
superficial skin infection who were more likely to be treated
with a more conservative approach and antibiotics only.
This approach appears adequate because there was an
excellent correlation between 18F-FDG uptakes results and
findings during the extraction as well as good mid-term
results in the subgroup of patients treated with antibiotics
0
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Figure 5
Receiver-Operating Characteristic Curve for 18F-FDG
PET/CT Semi-Quantitative Ratio for the Diagnosis of
Cardiovascular Implantable Electronic Device Infection
The receiver-operating characteristic curve revealed an area under the curve at
0.887 (p  0.001). Abbreviations as in Figure 1.only.
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PET/CT and Device Infection May 1, 2012:1616–25The result of a negative 18F-FDG PET/CT also pro-
ided useful additional information. It allowed a successful
onservative management in patients with initial suspicion
f CIED infection. In this subgroup of patients, 4 patients
ere treated successfully as a limited superficial skin infec-
ion without mid-term recurrence, 4 patients had bactere-
ia without evidence of device involvement and treated
uccessfully with intravenous antibiotics without recurrence
r need for lead extraction, 1 patient had bacteremia with an
bdominal source identified, and 1 patient was finally
iagnosed with reactive arthritis. A negative 18F-FDG
PET/CT probably avoided complete extraction in 6 patients.
On the basis of this information, we propose 2 algorithms
incorporating the 18F-FDG PET/CT in the evaluation and
management of patients with either initial CIED infection
suspicion (Fig. 6A) or patients with cardiac device and
bacteremia or fever of unknown origin (Fig. 6B).
Recent post-implantation changes. This study provides
unique information by including a new subgroup of patients
with recent device intervention, as these patients were
excluded from previous studies (15). As expected, a mild
level of residual inflammation was present in patients with a
recent intervention. However, using a semi-quantitative
ratio (ratio between maximal device count and normal lung
parenchyma), we were able to differentiate between residual
post-operative inflammation and an active infectious pro-
cess. The best combination of sensitivity and specificity was
obtained using a score of 1.5.
The site of 18F-FDG uptakes also appears important. In
patients with a recent intervention, the site of mild 18F-
FDG uptakes was usually located near the junction between
the leads and the connector. 18F-FDG uptakes around the
enerator and over the leads seem to be in favor of an
nfectious process. Because no significant 18F-FDG uptake
is present several months after the last intervention, chances
of a false positive after 6 months are very low. This confirms
results found in the study of Ploux et al. (15).
Correlation with transesophageal echocardiogram. Out
of 12 patients with suspected lead or valve vegetations noted
on TEE, 6 patients also had a positive 18F-FDG uptake in
he same anatomic location, confirming the diagnosis of
IED infection and lead infection. In the 6 other patients
ithout 18F-FDG uptakes, it is difficult to conclude if it
could be a false negative (i.e., infected vegetation without
uptake), a sterile vegetation, a fibrin strand, or a localized
thrombus. However, 3 patients with bacteremia and vege-
tation on TEE but negative 18F-FDG PET/CT were
successfully treated medically without long-term recurrence,
and 1 patient with vegetation on TEE but negative blood
culture and 18F-FDG PET/CT was found to have no active
infection. This favors the concept that many patients could
have strands around leads without infection and that 18F-
DG PET/CT could be the test of choice to confirm an
ctive infection (17). This may well change the initial
reatment strategy and may prevent unnecessary lead extrac-
ions. However, the sensitivity and specificity of this test inhis subgroup of patients are unknown. Further studies are
equired in order to clarify the appropriate management of
atients with suspected vegetation on TEE but negative
18F-FDG PET/CT.
Study limitations. The usefulness of 18F-FDG PET/CT
in slowly growing chronic infection is unknown. Prolonged
antibiotics therapy can probably lead to a negative 18F-FDG
PET/CT mainly if the focus is small or antibiotics have
been given for more than 1 week. The sensitivity and
specificity within the first post-operative month were not
evaluated in this study and are unknown, but likely lower.
18F-FDG PET/CT in patients with Parsonnet pouches,
Dacron pouch, or antibiotic mesh around devices have not
Figure 6 Algorithms
Proposed algorithms incorporating the 18F-FDG PET/CT in the evaluation and
management of patients with either initial CIED infection suspicion (A) or
patients with cardiac device and bacteremia or fever of unknown origin (FUO)
(B). Abbreviations as in Figure 1.been studied yet, but we report a case of false positive
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May 1, 2012:1616–25 PET/CT and Device Infection18F-FDG PET/CT in a patient with Dacron in his pocket.
Leukocyte scans were not systematically performed in this
study; although likely more specific, it has a lower resolution
than the 18F-FDG PET/CT. Longer follow-up will be
equired to ascertain that there is no late infection recur-
ence. The 2 proposed algorithms are now being tested
rospectively. Although no data are available on the
ost-effectiveness of this approach, it could be acceptable
f it avoids unnecessary lead extractions and device
e-implantations (estimated costs in Canada for a pace-
aker are $30,000 and for a defibrillator are $60,000 to
80,000, while the initial 18F-FDG PET/CT cost is less
han $2,500 in Canada).
onclusions
18F-FDG PET/CT is useful in differentiating between
cardiovascular implantable electronic device infection and
recent post-implantation changes, and to assess the
extension of the infectious process. Also, the absence of
abnormal 18F-FDG uptake among asymptomatic patients
mplanted with pacemaker or defibrillator for at least 6
onths suggest that there is no long-term uptake post-
mplant, hence a low risk of false positive after such time.
his imaging modality is promising for this new indica-
ion. It may guide appropriate therapy and help to limit
omplex and high-risk lead extractions to the more
ppropriate patients.
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